Inspire Medical Systems, Inc.
For the period ended Mar 31, 2026. Filed May 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 4, 2026
INSP$64.33+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Stockholders' Equity
Consolidated Statements of Stockholders' Equity (unaudited)
(in thousands, except share amounts)
| Three Months Ended March 31, 2026 | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares | Par Value | AdditionalPaid-InCapital | AccumulatedOtherComprehensiveIncome (Loss) | AccumulatedDeficit | TotalStockholders'Equity | |
| Balance at December 31, 2025 | 28,579,015 | $29 | $927,159 | $464 | $(146,492) | $781,160 |
| Stock options exercised, net | 2,343 | — | 109 | — | — | 109 |
| Vesting of restricted stock units and performance stock units, net | 219,816 | — | (7,591) | — | — | (7,591) |
| Issuance of common stock | 865 | — | 83 | — | — | 83 |
| Stock-based compensation expense | — | — | 30,689 | — | — | 30,689 |
| Other comprehensive loss, net of tax | — | — | — | (816) | — | (816) |
| Net loss | — | — | — | — | (11,294) | (11,294) |
| Balance at March 31, 2026 | 28,802,039 | $29 | $950,449 | $(352) | $(157,786) | $792,340 |
| Three Months Ended March 31, 2025 | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares | Par Value | AdditionalPaid-InCapital | AccumulatedOtherComprehensiveIncome (Loss) | AccumulatedDeficit | TotalStockholders'Equity | |
| Balance at December 31, 2024 | 29,740,176 | $30 | $981,043 | $536 | $(291,914) | $689,695 |
| Stock options exercised, net | 73,491 | — | 6,441 | — | — | 6,441 |
| Vesting of restricted stock units and performance stock units, net | 199,778 | — | (19,192) | — | — | (19,192) |
| Issuance of common stock | 390 | — | 69 | — | — | 69 |
| Stock-based compensation expense | — | — | 31,056 | — | — | 31,056 |
| Accelerated share repurchase of common stock | (103,886) | — | — | — | — | — |
| Share repurchase of common stock | (442,649) | (1) | (75,008) | — | — | (75,009) |
| Other comprehensive loss, net of tax | — | — | — | (309) | — | (309) |
| Net earnings | — | — | — | — | 2,992 | 2,992 |
| Balance at March 31, 2025 | 29,467,300 | $29 | $924,409 | $227 | $(288,922) | $635,743 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.